Blood cancer Clinical Trials in Uniondale, NY
As of August 2026, 28 paid clinical trials are recruiting for Blood cancer in Uniondale, New York. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
28 clinical trials for Blood cancer
·Clear filters·A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
A Dietary Study for People With Multiple Myeloma
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Top Research Study Locations in Uniondale
Researchers run research studies in Uniondale, NY at 18 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Memorial Sloan Kettering Nassau | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Breast Cancer | 69 |
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | Breast Cancer, Multiple Myeloma, Metastatic Breast Cancer | 69 |
| Memorial Sloan Kettering Nassau (All Protocol Activities) | Non-Small Cell Lung Cancer, Breast Cancer, Monoclonal Gammopathy of Undetermined Significance | 35 |
| Memorial Sloan Kettering Nassau (Consent Only) | Breast Cancer, Pancreatic Cancer, Prostate Cancer | 19 |
| Memorial Sloan Kettering at Nassau (Limited Protocol Activities) | Breast Cancer, Prostate Cancer, Adenocarcinoma of the Breast | 11 |
| MSK Nassau | Multiple Myeloma, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 7 |
| Memorial Sloan Kettering Cancer Center @ Nassau (Consent only) | GVHD, Graft-Versus-Host Disease, Ocular Tumor | 3 |
| MSK Nassau. | Advanced or Metastatic Solid Tumors, Brain Neoplasms, Cancer of the Prostate | 2 |
| Memorial Sloan Kettering Cancer Center @ Nassau (Limited Protocol Activities) | Advanced Solid Tumor, Metastatic Solid Tumor, Neuroendocrine Cancer | 2 |
| Memorial Sloan Kettering Nassau - Limited Protocol Activities | Clinical Stage: Stage II (T3-4, N-), Intrahepatic Cholangiocarcinoma, Rectal Adenocarcinoma | 2 |
| Memorial Sloan Kettering (Nassau) | Cervical Cancer | 1 |
| Memorial Sloan Kettering - Nassau | Non-small Cell Lung Cancer | 1 |
| Memorial Sloan Kettering Cancer Center - Nassau | Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations | 1 |
| Memorial Sloan Kettering Cancer Center Nassau | Locally Advanced Breast Cancer, Metastatic Breast Cancer, Unresectable Breast Carcinoma | 1 |
| Memorial Sloan Kettering Cancer Center at Nassau | Adenocarcinoma, Pancreatic Ductal | 1 |
| Memorial Sloan Kettering Nassau (Consent and Follow-Up) | Renal Cancer | 1 |
| Memorial Sloan Kettering Nassau (Limited Protocol Activity) | APC Gene Mutation, ATM Gene Mutation, BARD1 Gene Mutation | 1 |
| Memorial Sloan Kettering at Nassau (Consent and Followup) | Bone Neoplasm, Bone Sarcoma, Chondrosarcoma | 1 |
Active & Upcoming Studies in Uniondale (2026)
Recruiting trials in Uniondale grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (188 active studies)
- A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer · Phase 2 · Memorial Sloan Kettering Cancer Center
- A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma · Phase 1 · Memorial Sloan Kettering Cancer Center
Mental health & behavior (1 active study)
- A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home · Memorial Sloan Kettering Cancer Center
Diabetes & metabolic (1 active study)
- A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer · Phase 1 · Memorial Sloan Kettering Cancer Center
Neurology & pain (1 active study)
- A Study of Stereotactic Radiosurgery (SRS) to Treat Pain in the Chest and/or Stomach Wall · Phase 1 · Memorial Sloan Kettering Cancer Center
Pediatric (1 active study)
- A Study of 177Lu-PSMA-617 in People With Gliomas · Phase 1 · Memorial Sloan Kettering Cancer Center
Common conditions studied in Uniondale
- Breast Cancer (18 active studies)
- Multiple Myeloma (12 active studies)
- Non-Small Cell Lung Cancer (7 active studies)
- Prostate Cancer (7 active studies)
- Acute Myeloid Leukemia (6 active studies)
- Metastatic Breast Cancer (6 active studies)
Leading research sponsors in Uniondale
- Memorial Sloan Kettering Cancer Center
- National Cancer Institute (NCI)
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- Pfizer
Frequently asked questions
How many paid clinical trials are currently recruiting in Uniondale?
There are approximately 227 recruiting clinical trials in Uniondale, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Uniondale pay participants?
Most recruiting trials in Uniondale compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Uniondale?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Uniondale?
The most common conditions under active study in Uniondale include Breast Cancer (18), Multiple Myeloma (12), Non-Small Cell Lung Cancer (7), Prostate Cancer (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Uniondale?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Uniondale on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Uniondale?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Uniondale?
Recruiting research sites in Uniondale include Memorial Sloan Kettering Nassau, Memorial Sloan Kettering Nassau (Limited Protocol Activities), Memorial Sloan Kettering Nassau (All Protocol Activities), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Uniondale right now?
The largest active categories in Uniondale are Cancer & tumors (188), Mental health & behavior (1), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.